TY - JOUR ID - 69908 TI - Association of Glutathione-S-Transferases M1 and T1 Deletional Variants with Development of Oral Squamous Cell Carcinoma: A Study in the South-East of Iran JO - Asian Pacific Journal of Cancer Prevention JA - APJCP LA - en SN - 1513-7368 AU - Saravani, Shirin AU - Miri-Moghaddam, Masoud AU - Bazi, Ali AU - Miri-Moghaddam, Ebrahim AD - Oral and Dental Disease Research Center, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran. AD - Students Scientific Research Center, School of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran. AD - Clinical Research Development Unit, Amir-Al-Momenin Hospital, Zabol University of Medical Sciences, Zabol, Iran. AD - Cardiovascular Diseases Research Center and Department of Molecular Medicine, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran. Y1 - 2019 PY - 2019 VL - 20 IS - 6 SP - 1921 EP - 1926 KW - Squamous Cell Carcinoma KW - Glutathione S-transferase T1 KW - Glutathione S-transferase M1 DO - 10.31557/APJCP.2019.20.6.1921 N2 - Background: The role of genetic polymorphisms in genes of Glutathione-S-transferases (GST) enzymes in susceptibilityto oral cavity cancers is controversial. Oral Squamous Cell Carcinoma (OSCC) is the most common oral cavity neoplasm.Aimed to evaluate the potential impacts of two well-known null variants residing in the gene encoding GSTM1 andGSTT1 enzymes of OSCC patients in the southeast of Iran. Methods: In a case-control design, 113 individuals (50OSCC patients, and 63 healthy subjects) were included. DNA was extracted using paraffin-embedded tissues. GSTgenotyping was carried out using multiplex PCR. Results: In 113 participants, 41 (36.3%) and 72 (63.7%) were malesand females respectively. No significant difference was recognized for distribution of GSTM1 (P=0.11) and GSTT1(P=0.28) null genotypes between OSCC patients (58%, and 24% respectively) and healthy controls (42.9% and 15.9%respectively). Also, no significant difference was noted regarding the frequency of GSTM1 null genotype in differenthistological grades, however, those patients with more aggressive disease (poorly differentiated or grade III) revealedwith a significantly higher ratio (66.7%) of GSTT1 null genotype (P=0.002). The highest odds ratio for OSCC was relatedto combined null genotypes for GSTM1 and GSTT1 (OR=2.5, 95% CI: 0.7-9.2), however, this was not statisticallysignificant finding (P=0.15). Conclusion: Null genotypes polymorphisms were more common in OSCC than healthyindividuals. GSTT1 null genotype may be an important genetic factor in the progression of OSCC. UR - https://journal.waocp.org/article_69908.html L1 - https://journal.waocp.org/article_69908_79db533e5043e65b1736000c2fe9da0e.pdf ER -